Home/Filings/4/0001127602-13-007177
4//SEC Filing

Endicott David J. 4

Accession 0001127602-13-007177

CIK 0000850693other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 8:41 PM ET

Size

5.3 KB

Accession

0001127602-13-007177

Insider Transaction Report

Form 4
Period: 2013-02-15
Endicott David J.
CVP and President, AGN Med US
Transactions
  • Tax Payment

    Common Stock

    2013-02-15$108.02/sh225$24,30520,129 total
Holdings
  • Common Stock

    (indirect: By Trust)
    3,113.565
Footnotes (2)
  • [F1]Exempt disposition to the issuer, effective 2/15/2013, transaction date, of a number of shares determined to be sufficient to satisfy tax withholding obligations resulting from the lapse of restrictions of an exempt award of 609 shares of restricted stock granted on 2/17/2011.
  • [F2]Shares allocated to the reporting person's ESOP account as of reporting date.

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeother

Related Parties

1
  • filerCIK 0001532133

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 8:41 PM ET
Size
5.3 KB